Nicole Naumann Selected Research

talazoparib

10/2019

Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole Naumann Research Topics

Disease

11	Neoplasms (Cancer) 01/2021 - 02/2015
7	Eosinophilia 01/2022 - 09/2015
7	Systemic Mastocytosis 01/2022 - 09/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2020 - 01/2019
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2019 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019 - 01/2019
1	Hypersensitivity (Allergy) 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Leukemia 01/2022
1	Thrombocytosis (Thrombocythemia) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2020
1	Glioma (Gliomas) 02/2020
1	Anemia 11/2019
1	Thrombocytopenia (Thrombopenia) 11/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2019
1	Blast Crisis (Blast Phase) 09/2017
1	Splenomegaly 09/2015
1	Ascites 09/2015
1	Lymphadenopathy 09/2015
1	Disease Progression 02/2015
1	Alzheimer Disease (Alzheimer's Disease) 08/2010

Drug/Important Bio-Agent (IBA)

5	Tryptases (Tryptase)IBA 01/2022 - 09/2015
4	Imatinib Mesylate (Gleevec)FDA Link 02/2020 - 03/2016
3	midostaurinIBA 01/2022 - 01/2017
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 02/2015
2	ruxolitinibIBA 01/2020 - 02/2015
2	Hemoglobins (Hemoglobin)IBA 11/2019 - 09/2015
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2017 - 12/2015
1	Cladribine FDA LinkGeneric 01/2022
1	Contrast MediaIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Janus Kinase 2IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 02/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	RNA (Ribonucleic Acid)IBA 02/2020
1	Biomarkers (Surrogate Marker)IBA 02/2020
1	Phosphotransferases (Kinase)IBA 02/2020
1	nilotinib FDA Link 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2019
1	EndonucleasesIBA 10/2019
1	Decitabine FDA Link 10/2019
1	talazoparibIBA 10/2019
1	avapritinibIBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 08/2010
1	Proteins (Proteins, Gene)FDA Link 08/2010

Therapy/Procedure

3	Therapeutics 02/2020 - 02/2015
2	Stem Cell Transplantation 09/2017 - 02/2015
1	Premedication 01/2022
1	Chemoradiotherapy 02/2020
1	Withholding Treatment 01/2019
1	Drug Therapy (Chemotherapy) 09/2017